Analyst Ratings Coverage
CIBC World Markets (Rank#9) issued a research report on Aurora Cannabis, and lowered the 12 month target price to $.80 from $.85 per share. CIBC World Markets also maintained the “Neutral” rating.
ACB Stock Analysis
The Aurora Cannabis Inc stock forecast, compiled from the analysis of 9 analysts, provides insights into the projected performance of the company over the next 12 months. The average analyst target price for Aurora Cannabis Inc is CAD 1.29, suggesting an anticipated increase from the last closing price of CAD 0.64. This average target price reflects the consensus view among analysts that the stock has potential for upward movement in the specified time frame.
The average analyst rating for Aurora Cannabis Inc is categorized as “Buy,” indicating a general consensus among analysts that the stock is expected to perform well. Analysts typically arrive at these ratings by evaluating various factors, including the company’s financial health, industry trends, and potential growth prospects.
Stock Target Advisor, an independent stock analysis platform, has conducted its own assessment of Aurora Cannabis Inc and categorizes the stock as “Very Bearish.” This classification is based on 0 positive signals and 7 negative signals, suggesting a predominantly negative sentiment. The signals used in this analysis could cover a range of factors, such as financial metrics, market conditions, or other indicators that may impact the stock’s performance.
As of the last closing, Aurora Cannabis Inc’s stock price was CAD 0.64. Over the past week, the stock has experienced a marginal change of +0.00%, indicating relative stability. However, over the past month, it has shown a decline of -9.86%. Notably, over the last year, Aurora Cannabis Inc’s stock price has seen a substantial decrease, falling by -66.67%. This significant drop over the past year may be attributed to various factors, such as industry challenges, company-specific issues, or broader market trends affecting the cannabis sector.
